Cinclus Pharma Holding AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	487.25	566.72	87.97	173.55	138.2
Cash & Short-Term Investments	487.25	566.72	87.97	173.55	138.2
Cash Growth	-14.02%	544.20%	-49.31%	25.57%	-33.72%
Accounts Receivable	16.06	4.58	-	-	-
Other Receivables	5.9	2.93	3.98	10.23	1.38
Receivables	21.96	7.51	3.98	10.23	1.38
Prepaid Expenses	2.2	1.23	2.14	1.11	0.39
Other Current Assets	25.44	25.02	-	-	5.38
Total Current Assets	536.85	600.47	94.09	184.88	145.36
Property, Plant & Equipment	9.41	0.54	0.32	0.89	1.82
Other Long-Term Assets	0.3	0	0	0	0
Total Assets	546.56	601.01	94.41	185.77	147.18
Accounts Payable	48.46	18.93	16.45	16.95	9.19
Accrued Expenses	20.83	16.9	6.83	20.47	7.51
Short-Term Debt	-	-	131.01	-	-
Current Portion of Leases	3.11	0.11	0.02	0.54	0.85
Current Income Taxes Payable	0.21	7.45	7.22	5.4	-
Current Unearned Revenue	54.53	-	-	-	-
Other Current Liabilities	9.66	2.11	2.9	2.74	1.92
Total Current Liabilities	136.79	45.49	164.42	46.1	19.47
Long-Term Leases	4.79	0.19	-	-	0.61
Long-Term Unearned Revenue	35.59	-	-	-	-
Other Long-Term Liabilities	-0	-	6.79	12.8	-
Total Liabilities	177.17	45.68	171.21	58.9	20.08
Common Stock	0.92	0.92	0.51	0.51	0.26
Additional Paid-In Capital	1,298	1,298	503.52	503.69	276.74
Retained Earnings	-952.8	-772	-606.84	-394.16	-145.08
Comprehensive Income & Other	23.53	28.67	26	16.84	-4.82
Shareholders' Equity	369.39	555.33	-76.8	126.87	127.1
Total Liabilities & Equity	546.56	601.01	94.41	185.77	147.18
Total Debt	7.9	0.3	131.03	0.54	1.46
Net Cash (Debt)	479.36	566.42	-43.06	173	136.75
Net Cash Growth	-15.37%	-	-	26.51%	-34.41%
Net Cash Per Share	10.29	15.29	-1.64	7.51	6.48
Filing Date Shares Outstanding	46.54	46.54	26.23	0.33	0.26
Total Common Shares Outstanding	46.54	46.54	26.23	0.33	0.26
Working Capital	400.06	554.97	-70.33	138.78	125.89
Book Value Per Share	7.94	11.93	-2.93	387.00	481.30
Tangible Book Value	369.39	555.33	-76.8	126.87	127.1
Tangible Book Value Per Share	7.94	11.93	-2.93	387.00	481.30

Source: S&P Global Market Intelligence. Standard template. Financial Sources.